MeVis Medical Solutions AG (FRA:M3V)

FRA:M3V Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 24, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Market Capitalization	47	42	52	62	59	58
Market Cap Growth	5.79%	-19.01%	-16.96%	4.91%	2.52%	6.71%
Enterprise Value	44	37	47	58	55	55
Last Close Price	24.60	21.97	25.90	30.26	27.96	27.29
PE Ratio	10.83	9.18	10.51	7.99	13.05	10.15
PS Ratio	2.80	2.47	2.98	3.32	3.66	3.38
PB Ratio	2.61	2.35	2.90	3.49	3.33	3.25
P/TBV Ratio	2.61	2.35	2.90	3.49	3.33	3.25
P/FCF Ratio	-	14.72	8.95	13.18	6.53	20.76
P/OCF Ratio	-	13.30	8.83	12.81	6.50	20.03
EV/Sales Ratio	2.65	2.18	2.73	3.09	3.41	3.20
EV/EBITDA Ratio	12.51	8.99	9.53	8.83	10.75	9.57
EV/EBIT Ratio	13.07	9.29	9.72	8.96	11.02	9.86
EV/FCF Ratio	-	13.00	8.19	12.26	6.09	19.67
Asset Turnover	0.68	0.62	0.59	0.64	0.59	0.66
Quick Ratio	3.70	4.13	3.99	4.68	4.41	26.22
Current Ratio	4.21	4.13	4.10	4.78	4.56	27.24
Return on Equity (ROE)	24.14%	25.59%	27.60%	43.70%	25.50%	32.00%
Return on Assets (ROA)	8.64%	9.13%	10.26%	13.76%	11.33%	13.45%
Return on Capital (ROIC)	11.81%	13.96%	17.05%	22.67%	17.59%	19.50%
Return on Capital Employed (ROCE)	15.30%	16.50%	19.20%	22.90%	19.90%	20.30%
Earnings Yield	9.24%	10.90%	9.52%	12.51%	7.66%	9.86%
FCF Yield	-	6.79%	11.17%	7.59%	15.30%	4.82%
Dividend Yield	3.71%	5.14%	3.67%	-	-	-
Total Shareholder Return	3.71%	5.14%	3.67%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.